JUMP Inflammatory Bowel Disease Study
JUMP IBD
The Feasibility of Jumping Based Exercise to Improve Musculoskeletal Outcomes in Children and Adolescents With Inflammatory Bowel Disease (The JUMP IBD Study)
1 other identifier
interventional
15
1 country
1
Brief Summary
Children and adolescents with inflammatory bowel disease are at increased risk of poor bone and muscle health through a variety of factors, including underlying disease processes, nutritional deficits, and reduced physical activity. Inflammatory bowel disease can also delay the onset of puberty in children, and pubertal development in adolescents, resulting in sub-optimal adult bone mass, therefore increasing future risk of fractures and osteoporosis. High impact exercise may be a useful additional therapy for adolescents with IBD, as the mechanical strains produced during this type of exercise, through high force muscular contractions and ground reaction forces, can promote bone formation and gains in muscle mass. There have been no previous studies assessing the effects of high impact exercise in IBD, so it is unknown if this type of exercise is feasible in this population. The aim of this study is to assess the feasibility of a short term jumping based exercise intervention for improving muscle and bone outcomes in children and adolescents with inflammatory bowel disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 25, 2019
CompletedStudy Start
First participant enrolled
August 1, 2019
CompletedFirst Posted
Study publicly available on registry
August 28, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2021
CompletedAugust 28, 2019
August 1, 2019
1.9 years
July 25, 2019
August 23, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Adherence to exercise protocol
Number of exercise repetitions/sessions completed
4 weeks
Secondary Outcomes (8)
Bone metabolism biomarker
Baseline and 4 weeks
Growth hormone axis
Baseline and 4 weeks
Inflammatory cytokines
Baseline and 4 weeks
Muscle function
Baseline and 4 weeks
Disease activity
Baseline and 4 weeks
- +3 more secondary outcomes
Study Arms (1)
Jumping exercise
EXPERIMENTALHigh-impact exercise intervention: 3 sessions per week for four weeks Each session will consist of three jumping-based exercises, performed for three sets of various repetitions, following a progressive protocol with increasing volume/intensity.
Interventions
Four weeks of three jumping-based exercise sessions per week. These sessions will involve basic jumping movements, with approximately 50-100 jumps per session; incorporating 20-30 minutes of exercise.
Eligibility Criteria
You may qualify if:
- confirmed diagnosis of inflammatory bowel disease (Crohn's disease or ulcerative colitis) at least 6 months prior to study involvement
- aged 10 to 17.9 years (inclusive)
- ability to provide written informed consent, or assent with accompanying parent/guardian consent
- ability to mobilise and perform exercise independently
- disease in remission, or mildly/moderately active, according to weighted Paediatric Crohn's disease activity index (wPCDAI) or Paediatric ulcerative colitis activity index (PUCAI)
- stable medication for \>4 weeks prior to study, and no planned changes of medication during study period
You may not qualify if:
- lack of capacity to provide consent or assent
- pregnancy (females)
- recent (\<12 weeks) surgery, or planned surgery during intervention period
- significant contraindication to high-impact exercise
- significant comorbidity
- use of medication known to affect bone turnover (excluding that used to treat IBD \[i.e. glucocorticoids\])
- BMI \> +3.5 standard deviation score (SDS)
- participating in \>2 hours per week structured exercise (excluding school physical education)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- NHS Greater Glasgow and Clydelead
- University of Glasgowcollaborator
Study Sites (1)
NHS Greater Glasgow and Clyde
Glasgow, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jarod Sze Choong Wong, MBBS MRCPCH DMedSc
University of Glasgow
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 25, 2019
First Posted
August 28, 2019
Study Start
August 1, 2019
Primary Completion
July 1, 2021
Study Completion
July 1, 2021
Last Updated
August 28, 2019
Record last verified: 2019-08
Data Sharing
- IPD Sharing
- Will not share